You are here

CHS Directory

Displaying 176 - 200 of 1210

Please contact us to request changes to what portion of your contact information is displayed.

First Name Last Name E-mail Telephone Institutionsort descending Area of Expertise Address 1 Address 2 City State ZIP
Mary Lou Biggs mlbiggs@u.washington.edu 206-897-1945 University of Washington cancer, Diabetes Mellitus, Statistical methods Collaborative Health Studies Coordinating Center, Campus Box 354922 Building 29, Suite 210 Seattle Washington 98115
Mark Willcox mwillcox@cardiology.washington.edu 2023411823 University of Washington cardiology 214 Summit Ave E #201 Seattle Washington 98102
Stephen Thielke sthielke@u.washington.edu 206 764-2915 University of Washington Longitudinal Analysis, Mental health Psychiatry and Behavioral Sciences Seattle Washington 98195
Petra Buzkova buzkova@u.washington.edu 206-897-1962 University of Washington Bone Mineral Density, Statistical methods Collaborative Health Studies Coordinating Center, Campus Box 354922 Building 29, Suite 210 Seattle Washington 98115
Noel Weiss nweiss@u.washington.edu 206-685-1788 University of Washington Department of Epidemiology Box 357236, HSB F-261F Seattle Washington 98195
Marlena Maziarz marlena.maziarz@gmail.com University of Washington Collaborative Health Studies Coordinating Center, Campus Box 354922 Building 29, Suite 210 Seattle Washington 98115-8160
Nisha Bansal nbansal@uw.edu University of Washington chronic renal disease, renal Washington
Shelly Gray slgray@u.washington.edu 206-616-5061 University of Washington Health Sciences Building H-361D Box 357630 Seattle Washington 98195
Brandon Pierce bleep@u.washington.edu University of Washington School of Public Health and Community Medicine Institute for Public Health Genetics Seattle Washington 98195
Jenny Yi-Chen Hsieh yhsieh3@uw.edu 2062902370 University of Washington adults, age -related, age at menopause, Aging, Atherosclerotic Cardiovascular Disease, cardioembolic stroke, cardiometabolic disease, cardiometabolic risk, cardiometabolic risk factors, cardiovascular, cardiovascular medication, cardiovascular and thrombotic risk factors, cardiovascular damage, cardiovascular death, cardiovascular disease, cardiovascular disease (CVD), cardiovascular disease epidemiology, cardiovascular disease prediction, cardiovascular disease risk factors, cardiovascular events, cardiovascular exposure, cardiovascular health, cardiovascular health study, Cardiovascular Health Study (CHS), cardiovascular medications, cardiovascular morbitidy, cardiovascular mortality, cardiovascular outcomes, Cardiovascular Prevention, cardiovascular risk, cardiovascular risk factors, cardiovascular risk prediction, caregiver, caregiving, clinical epidemiology; nutrition; heart failure, CLINICAL HEART DISEASE, congestive heart failure, congestive heart failure (CHF), coronary heart disease, coronary heart disease (CHD), coronary heart disease and stroke, disability; cognitive; Medicare; stroke, functional assessment, functional decline, functional dependence, Geriatric Cardiology, Geriatric conditions, Geriatric Heart Failure, geriatric impairment, Geriatric medicine, geriatric medicine and assessment, geriatric syndrome, Geriatrics, Heart, heart failure, heart failure outcomes, Heart failure phenotype. HFpeF, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, hemorrhagic stroke, incident CHD, incident CHF, incident CVD, incident heart failure, incident stroke, independent activities of daily living (IADL), ischemic heart disease, ischemic stroke, morbidity, mortality, mortality rate, mortality risk, neurobiomarkers, neurofilament light chain, neurofilament llight chain, NT-proBNP, older adult, older adults, postmenopausal estrogen, postmenopausal estrogen, postmenopausal hormone therapy, Postmenopausal hormones, Prevalent CHD, prevalent disease, prevention, preventive, Public Health, public health impact, SEX DIFFERENCES, SOCIOECONOMIC INDICATORS, stroke, stroke in middle age, Stroke incidence, stroke prediction, stroke risk model, stroke severity, survival analysis, vascular disease 3980 15th Ave NE Seattle Washington 98105
Peifeng Hu Phu@mednet.ucla.edu 310-825-8253 UCLA David Geffen School of Medicine Division of Geriatrics Los Angeles California 90095
Sharon Stein Merkin smerkin@mednet.ucla.edu 310-825-8253 UCLA disparities, epidemiological studies, social determinants of health David Geffen School of Medicine Division of Geriatrics Los Angeles California 90095
PP User 1 root@example.com UCLA California
Lenore Arab larab@ucla.edu UCLA neurology David Geffen School of Medicine 12-262 Factor Bldg Los Angeles California 90095
Shilpa Sharma shilpasharma@mednet.ucla.edu UCLA Acute Kidney Injury, Phosphate N/A
Arleen Brown abrown@mednet.ucla.edu 310-794-6047 UCLA diabetes, Neighborhood socioeconomic status, social determinants of health 1100 Glendon Avenue, Suite 850 GIM and HSR Los Angeles California 90024
David Liebeskind DLiebeskind@mednet.ucla.edu UCLA N/A
SC User 1 root@example.org NYU New York
Daniele Massera daniele.massera@gmail.com 3478567382 NYU cardiology 530 1st Avenue, HCC Suite 4H New York New York 10016
Tomasz Beben tbeben@ucsd.edu (858)-552-8585 ext: 7337 UCSD Nephrology, Geriatrics Division of Nephrology-Hypertension (9111H) 3350 La Jolla Village Drive San Diego California 92161
Jonathan Cheng j3cheng@health.ucsd.edu 909-569-7310 UCSD 25(OH)D, 25-dihydroxy, 25-hydroxyvitamin D, chronic kidney disease, serum 25-hydroxyvitamin D concentration (25(OH)D) 9452 Medical Center Dr, L3E206 La Jolla California 92037
Vera Bittner vbittner@uab.edu 205-934-7336 University of Alabama at Birmingham UAB Station - LHRB 310 Birmingham Alabama 35294
Naman Shetty nsshetty@uabmc.edu University of Alabama at Birmingham congestive heart failure, congestive heart failure (CHF); genetic; GWAS, n-terminal of the prohormone brain natriuretic peptide, Natriuretic peptides N/A
Pankaj Arora parora@uabmc.edu University of Alabama at Birmingham amino-terminal B-type natriuretic peptide (NT-proBNP), ANP, anti-hypertensive medication, Anti-Hypertensive Therapy, cardiac biomarkers, GWAS, GWAS meta-analysis, heart failure, heart failure outcomes, Heart failure phenotype. HFpeF, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, heart failure; genetics, heart failure; GWAS; multiomics; electrical dyssynchrony; global electrical heterogeneity N/A
Alana Jones acjones@uab.edu University of Alabama at Birmingham ..... N/A

Pages